X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (55) 55
oncology (42) 42
index medicus (34) 34
female (24) 24
risk factors (21) 21
cancer (19) 19
neoplasms - complications (19) 19
neoplasms - drug therapy (19) 19
chemotherapy (16) 16
deep-vein thrombosis (14) 14
male (14) 14
aged (13) 13
mortality (13) 13
middle aged (12) 12
treatment outcome (12) 12
venous thromboembolism - prevention & control (12) 12
research (11) 11
venous thromboembolism (11) 11
risk assessment (10) 10
adult (9) 9
antineoplastic agents - adverse effects (9) 9
cell lung-cancer (9) 9
medicine & public health (9) 9
neutropenia - chemically induced (9) 9
patients receiving chemotherapy (9) 9
randomized controlled trials as topic (9) 9
thromboembolism (9) 9
thrombosis (9) 9
venous thromboembolism - etiology (9) 9
anticoagulants - therapeutic use (8) 8
breast-cancer (8) 8
cancer patients (8) 8
granulocyte colony-stimulating factor - therapeutic use (8) 8
hematology (8) 8
non-hodgkins-lymphoma (8) 8
survival (8) 8
american society (7) 7
article (7) 7
colony-stimulating factor (7) 7
febrile neutropenia (7) 7
health aspects (7) 7
molecular-weight heparin (7) 7
neutropenia - drug therapy (7) 7
practice guidelines as topic (7) 7
prognosis (7) 7
prophylaxis (7) 7
prospective studies (7) 7
survival analysis (7) 7
therapy (7) 7
venous thromboembolism - drug therapy (7) 7
breast neoplasms - drug therapy (6) 6
neoplasms (6) 6
neoplasms - mortality (6) 6
neutropenia - prevention & control (6) 6
peripheral vascular disease (6) 6
prevention (6) 6
pulmonary embolism (6) 6
pulmonary-embolism (6) 6
risk-factors (6) 6
surgical adjuvant breast (6) 6
united states (6) 6
anticoagulation (5) 5
antineoplastic agents - therapeutic use (5) 5
breast cancer (5) 5
breast neoplasms - pathology (5) 5
infection (5) 5
multivariate analysis (5) 5
neutropenia (5) 5
risk (5) 5
unfractionated heparin (5) 5
venous thromboembolism - complications (5) 5
warfarin (5) 5
antineoplastic combined chemotherapy protocols - adverse effects (4) 4
care and treatment (4) 4
chemotherapy, adjuvant (4) 4
cost-benefit analysis (4) 4
disease-free survival (4) 4
dose-intensity (4) 4
dose-response relationship, drug (4) 4
drug therapy (4) 4
fatal pulmonary-embolism (4) 4
fever - drug therapy (4) 4
fever - etiology (4) 4
guidelines (4) 4
hematology, oncology and palliative medicine (4) 4
hemorrhage - chemically induced (4) 4
heparin (4) 4
logistic models (4) 4
lymphomas (4) 4
medicine, general & internal (4) 4
morbidity (4) 4
neoplasms - blood (4) 4
neoplasms - therapy (4) 4
neutropenia - economics (4) 4
predictive value of tests (4) 4
reproducibility of results (4) 4
abridged index medicus (3) 3
aged, 80 and over (3) 3
analysis (3) 3
antineoplastic agents - administration & dosage (3) 3
more...
Library Location Library Location
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Journal of Clinical Oncology, ISSN 0732-183X, 02/2016, Volume 34, Issue 5, pp. 517 - 518
Journal Article
Blood, ISSN 0006-4971, 11/2019, Volume 134, Issue Supplement_1, pp. 3673 - 3673
Introduction: Venous thromboembolism (VTE) affects ~20% of patients with cancer prior to death and may be present in up to half of cancer patients upon... 
Journal Article
Journal Article
Journal of Thrombosis and Haemostasis, ISSN 1538-7933, 12/2019, Volume 17, Issue 12, pp. 2141 - 2151
Background It is unclear if direct oral anticoagulant (DOAC) is efficacious and safe for prophylaxis of venous thromboembolism (VTE) in ambulatory patients... 
neoplasm | rivaroxaban | factor Xa inhibitors | apixaban | venous thromboembolism
Journal Article
Blood, ISSN 0006-4971, 11/2018, Volume 132, Issue Supplement 1, pp. 3798 - 3798
Abstract Introduction: Venous thromboembolism (VTE) is common in cancer patients and associated with adverse consequences. Risk factors for cancer-associated... 
Journal Article
Blood, ISSN 0006-4971, 11/2018, Volume 132, Issue Supplement 1, pp. 3799 - 3799
Abstract Introduction: Venous thromboembolism (VTE) is a cause of significant morbidity and mortality in cancer patients and its prevalence in this population... 
Journal Article
Blood, ISSN 0006-4971, 11/2019, Volume 134, Issue Supplement_1, pp. 4669 - 4669
Introduction: Randomized controlled trials (RCTs) have shown similar yet conflicting primary outcomes for the use of low-dose direct oral anticoagulant (DOAC),... 
Journal Article
Cancer, ISSN 0008-543X, 03/2007, Volume 109, Issue 6, pp. 1011 - 1018
Journal Article
Blood, ISSN 0006-4971, 12/2016, Volume 128, Issue 22, pp. 4751 - 4751
Background: Venous thromboembolism (VTE) represents a leading cause of morbidity and mortality among hospitalized patients with cancer. Methods:... 
Journal Article
Cancer investigation, 09/2019, p. 1
Journal Article
Blood, ISSN 0006-4971, 12/2016, Volume 128, Issue 22, pp. 534 - 534
Abstract Background Patients with multiple myeloma (MM) have a 9-fold increased risk of developing venous thromboembolism (VTE). Current guidelines recommend... 
Journal Article
Journal of Clinical Oncology, ISSN 0732-183X, 02/2017, Volume 35, Issue 4_suppl, pp. 280 - 280
280 Background: Clinical trials suggest that patients with mPDA are at high risk of TE from both disease and treatment. TE rates and anticoagulant use among... 
Journal Article
Blood, ISSN 0006-4971, 12/2014, Volume 124, Issue 21, pp. 2613 - 2613
Background: Venous thromboembolism (VTE) occurs commonly in patients with cancer and is associated with considerable morbidity and mortality. While the risk of... 
Journal Article
Journal of the National Cancer Institute, ISSN 0027-8874, 12/2010, Volume 103, Issue 24, pp. 1901 - 1903
Journal Article
2011, 1, Cancer treatment and research, ISBN 9781441970725, Volume 157., xv, 433
This volume reviews and integrates the major advances in our understanding of the underlying molecular biology and pharmacology of hematopoietic growth factors... 
drug therapy | pharmacology | Oncology | Mechanism of action | therapeutic use | Neoplasms | Hematopoietic growth factors | Colony-Stimulating Factors | Clinical & internal medicine | Colony-Stimulating Factors - therapeutic use | Medicine & Public Health | Cancer
Book
No results were found for your search.

Cannot display more than 1000 results, please narrow the terms of your search.